These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31085822)

  • 1. A suggested algorithm for detection of multi drug-resistant tuberculosis in Zimbabwe.
    Makamure B; Makumbirofa S; Bandason T; Leccese P; Mutetwa R; Robertson V; Mason P
    J Infect Dev Ctries; 2017 Sep; 11(8):611-618. PubMed ID: 31085822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of microscopic observation drug susceptibility assay for diagnosis of multidrug-resistant tuberculosis in Viet Nam.
    Dang TM; Nguyen TN; Wolbers M; Vo SK; Hoang TT; Nguyen HD; To MH; Vuong MB; Nguyen TP; Tran VQ; Nguyen TB; Vo TH; Nguyen TN; Dai VH; Phan TH; Nguyen HD; Farrar J; Caws M
    BMC Infect Dis; 2012 Mar; 12():49. PubMed ID: 22375832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microscopic-observation drug-susceptibility assay for the diagnosis of drug-resistant tuberculosis in Harare, Zimbabwe.
    Makamure B; Mhaka J; Makumbirofa S; Mutetwa R; Mupfumi L; Mason P; Metcalfe JZ
    PLoS One; 2013; 8(2):e55872. PubMed ID: 23409072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Microscopic observation drug susceptibility (MODS) assay as a rapid, sensitive and inexpensive test for detection of tuberculosis and multidrug resistant tuberculosis.
    Agarwal A; Katoch CDS; Kumar M; Dhole TN; Sharma YK
    Med J Armed Forces India; 2019 Jan; 75(1):58-64. PubMed ID: 30705479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of GeneXpert Mycobacterium tuberculosis/rifampicin for rapid detection of rifampicin resistant Mycobacterium tuberculosis strains of clinically suspected multi-drug resistance tuberculosis cases.
    Guenaoui K; Harir N; Ouardi A; Zeggai S; Sellam F; Bekri F; Cherif Touil S
    Ann Transl Med; 2016 May; 4(9):168. PubMed ID: 27275481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of Cepheid ® Xpert MTB/RIF ® and TB-Biochip ® MDR in two regions of Russia with a high prevalence of drug-resistant tuberculosis.
    Kurbatova EV; Kaminski DA; Erokhin VV; Volchenkov GV; Andreevskaya SN; Chernousova LN; Demikhova OV; Ershova JV; Kaunetis NV; Kuznetsova TA; Larionova EE; Smirnova TG; Somova TR; Vasilieva IA; Vorobieva AV; Zolkina SS; Cegielski JP
    Eur J Clin Microbiol Infect Dis; 2013 Jun; 32(6):735-43. PubMed ID: 23263819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Accuracy of GeneXpert MTB/RIF Assay in Comparison to Conventional Drug Susceptibility Testing Method for the Diagnosis of Multidrug-Resistant Tuberculosis.
    Pandey P; Pant ND; Rijal KR; Shrestha B; Kattel S; Banjara MR; Maharjan B; Kc R
    PLoS One; 2017; 12(1):e0169798. PubMed ID: 28081227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of microscopic observation drug susceptibility for the rapid diagnosis of tuberculosis and detection of drug resistance in Bamako, Mali.
    Sanogo M; Kone B; Diarra B; Maiga M; Baya B; Somboro AM; Sarro YS; Togo ACG; Dembele BPP; Goita D; Kone A; M'Baye O; Coulibaly N; Diabate S; Traore B; Diallo MH; Coulibaly YI; Saleeb P; Belson M; Orsega S; Siddiqui S; Polis MA; Dao S; Murphy RL; Diallo S
    Clin Microbiol Infect; 2017 Jun; 23(6):408.e1-408.e6. PubMed ID: 28110049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay.
    Shah NS; Moodley P; Babaria P; Moodley S; Ramtahal M; Richardson J; Heysell S; Li X; Moll A; Friedland G; Sturm AW; Gandhi NR
    Am J Respir Crit Care Med; 2011 May; 183(10):1427-33. PubMed ID: 21297071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent evaluation of microscopic observation of drug susceptibility assay for pulmonary and extrapulmonary tuberculosis.
    Zadbuke SS; Set R; Khan N; Shastri J
    J Lab Physicians; 2017; 9(2):89-94. PubMed ID: 28367022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial experience with GeneXpert MTB/RIF assay in the Arkansas Tuberculosis Control Program.
    Patil N; Saba H; Marco A; Samant R; Mukasa L
    Australas Med J; 2014; 7(5):203-7. PubMed ID: 24944716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of MDR-TB and XDR-TB in China: a prospective multicentre study.
    Huang Z; Qin C; Du J; Luo Q; Wang Y; Zhang W; Zhang X; Xiong G; Chen J; Xu X; Li W; Li J
    J Antimicrob Chemother; 2015 Feb; 70(2):456-62. PubMed ID: 25266071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular diagnosis, genetic diversity and drug sensitivity patterns of Mycobacterium tuberculosis strains isolated from tuberculous meningitis patients at a tertiary care hospital in South India.
    Krishnakumariamma K; Ellappan K; Muthuraj M; Tamilarasu K; Kumar SV; Joseph NM
    PLoS One; 2020; 15(10):e0240257. PubMed ID: 33017455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Xpert® MTB/Rif test, microscopic observation drug susceptibility test and nitrate reductase assay, for rapid and accurate diagnosis of smear-negative tuberculosis in HIV patients.
    Walusimbi S; Bwanga F; Costa AD; Haile M; Hoffner S; Joloba M
    Int J Mycobacteriol; 2013 Sep; 2(3):148-55. PubMed ID: 26785983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania.
    Pimkina E; Zablockis R; Nikolayevskyy V; Danila E; Davidaviciene E
    Respir Med; 2015 Nov; 109(11):1484-9. PubMed ID: 26403251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic efficiency of Xpert MTB/RIF assay for osteoarticular tuberculosis in patients with inflammatory arthritis in China.
    Li Y; Jia W; Lei G; Zhao D; Wang G; Qin S
    PLoS One; 2018; 13(6):e0198600. PubMed ID: 29856840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the tuberculosis culture color plate test for rapid detection of drug susceptible and drug-resistant Mycobacterium tuberculosis in a resource-limited setting, Addis Ababa, Ethiopia.
    Mekonnen B; Mihret A; Getahun M; Hailu T; Sidiki S; V Kelley H; Scordo JM; Hunt WG; Pan X; Balada-Llasat JM; Gebreyes W; Evans CA; Aseffa A; Torrelles JB; Wang SH; Abebe T
    PLoS One; 2019; 14(5):e0215679. PubMed ID: 31136575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe.
    Ndlovu Z; Fajardo E; Mbofana E; Maparo T; Garone D; Metcalf C; Bygrave H; Kao K; Zinyowera S
    PLoS One; 2018; 13(3):e0193577. PubMed ID: 29499042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of WHO-Endorsed Rapid Tests for Detection of Susceptibility to First-Line Drugs in Patients with Pulmonary Tuberculosis in Bangladesh.
    Rahman SMM; Ather MF; Nasrin R; Hoque MA; Khatun R; Rahman T; Uddin MKM; Ahmed S; Banu S
    Diagnostics (Basel); 2022 Feb; 12(2):. PubMed ID: 35204501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteriological diagnosis of childhood TB: a prospective observational study.
    Brent AJ; Mugo D; Musyimi R; Mutiso A; Morpeth SC; Levin M; Scott JAG
    Sci Rep; 2017 Sep; 7(1):11808. PubMed ID: 28924198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.